My PCR
Create Account
Logo PCR

26 May 2021

CTOStable CADChronic heart failure

EuroPCR 2021 Hotlines / Late-Breaking Trials: PLA-pCi-EBO-pilot, CALM, ISCHEMIA, and more!

Session comprising selected EuroPCR 2021 Hotlines & Late-Breaking Trials submissions

D. Khelimskii, C.W. Nam, E. Navarese, H. Sievert, M. Wester

Summary

Find out more about various studies & registries in stable CAD:

  • Effects of visualization of PCI results on symptoms in chronic coronary syndrome
  • Effect of Atorvastatin Therapy on Serial Changes of Coronary Flow And Plaque
  • Initial results of a feasibility study of endovascular baroreflex amplification in heart failure patients
  • Impact of successful CTO PCI on clinical outcomes of patients with reduced LVEF
  • Cardiac mortality with elective coronary revascularisation vs medical therapy

Presentations available when logged in:

  • Effects of visualization of PCI results on symptoms in chronic coronary syndrome
  • Effect of Atorvastatin Therapy on Serial Changes of Coronary Flow And Plaque
  • Initial results of a feasibility study of endovascular baroreflex amplification in heart failure patients
  • Impact of successful CTO PCI on clinical outcomes of patients with reduced LVEF
  • Meta-analysis of elective coronary revascularisation vs. medical therapy alone
Related Content
OCT- vs angiography-guided coronary stent implantation in calcified lesions: the ILUMIEN IV trial Improving Heart Function (iHF): Driving trans-disciplinary innovation in heart failure care Share your work at PCR-CIT China Chengdu Valves 2025
Recommended for you
AICT-AsiaPCR: what's in store this year? What's the best way to reduce the cost of your #AictPCR badge? AICT-AsiaPCR: Call for Submissions is now open